Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-25 @ 2:37 AM
NCT ID:
NCT01096134
Eligibility Criteria:
Inclusion Criteria:
* Age 9-13 at first HPV vaccine dose
* Mother/legal guardian and daughter are both interested and willing to have the girl receive the HPV vaccine
* Mother/legal guardian and daughter both indicate that they would be able to return to clinic for the three vaccine doses
Exclusion Criteria:
* Girls with a known history of any allergies or severe reaction to any vaccines, food or medicine
* Pregnant adolescents will be excluded. If a girl becomes pregnant after the first dose is administered, she will not be provided with the second or third dose
* Girls with moderate or severe illnesses will be asked to postpone vaccination eg. Pneumonia.
* Girls with a weakened immune system, cancer, leukemia, AIDS or other immune system problems
* Girls with a bleeding disorder or currently taking anticoagulants
* Girls that have received any other vaccinations in the past 4 weeks
* Girls currently on steroids, such as cortisone, prednisone, or anti-cancer drug.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
9 Years
Maximum Age:
13 Years
Study:
NCT01096134
Study Brief:
Protocol Section:
NCT01096134